TB represents an underestimated global health problem and economic burden. The medical need in TB arises from the sheer amount of people carrying a latent infection leading to novel outbreaks and fatalities. Supposedly novel diagnostic solutions have not met market needs and hence health systems around the world still largely rely on TB skin tests that are time-consuming, error-prone and ineffective.